Opinion
Congress Can't Wait—Reform Pharmacy Benefit Managers and Deliver Lower-Cost Drugs for Patients | Opinion
The PBM system intentionally blocks lower-cost, FDA-approved biosimilars from being available to patients. Biosimilars are the commonsense, bipartisan solution to out-of-control prescription drug ...
Online pharmacies are accused of treating fat jabs 'like ­grocery items at a Lidl checkout' amid demands to tighten access rules
The National Pharmacy Association (NPA) has written to regulators following reports that some online sellers are setting ...